咽鼓管圆枕淀粉样变性伴中耳积液1例并文献复习

doi:10.6040/j.issn.1673-3770.0.2023.330

Abstract

Abstract: Objective The purpose of this study is to investigate the clinical characteristics and treatment of localized amyloidosis of torus tubalis. Methods We retrospectively analyzed the amyloidosis of torus tubalis with middle ear effusion, summarized the characteristics, performed diagnosis of the clinical case, and reviewed relevant literature. Results The patient had repeated hydrops in the left middle ear, and conservative treatment was poor for this case. Electronic nasopharynx examination showed bilateral torus tubalis hypertrophy, and amyloidosis was recommended after biopsy. The examination was completed to exclude systemic amyloidosis. Lesions of bilateral torus tubalis were removed through operation with low-temperature plasma radio-frequency ablation. After one year of follow-up, the patient recovered well, and no recurrence or progression to systemic amyloidosis was observed. Conclusion Amyloidosis is rare in the torus tubalis. Surgical treatment is feasible when the clinical symptoms are not treated conservatively. In particular, it is crucial to exclude systemic amyloidosis, and postoperative follow-up should be closely followed.

Key words: Amyloidosis, Torus tubalis, Middle ear effusion

CLC Number:

R766.3

LIN Yunxian, MA Lingguo. Amyloidosis of torus tubalis with middle ear effusion: a case report with literature review[J].Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 86-90.

References

[1] Vaxman I, Gertz M. When to suspect a diagnosis of amyloidosis[J]. Acta Haematol, 2020, 143(4): 304-311. doi:10.1159/000506617
[2] Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: a systematic review[J]. JAMA, 2020, 324(1): 79-89. doi:10.1001/jama.2020.5493
[3] Kourelis TV, Kyle RA, Dingli D, et al. Presentation and outcomes of localized immunoglobulin light chain amyloidosis: the mayo clinic experience[J]. Mayo Clin Proc, 2017, 92(6): 908-917. doi:10.1016/j.mayocp.2017.02.016
[4] Al-Obaidy KI, Grignon DJ. Primary amyloidosis of the genitourinary tract[J]. Arch Pathol Lab Med, 2021, 145(6): 699-703. doi:10.5858/arpa.2020-0102-RA
[5] Celenk F, Durucu C, Baysal E, et al. Management of upper aerodigestive tract amyloidosis[J]. Ann Otol Rhinol Laryngol, 2013, 122(8): 535-540. doi:10.1177/000348941312200810
[6] Wahid NW, Abed T, Meghji S, et al. Localized sinonasal amyloidosis[J]. Allergy Rhinol, 2019, 10: 2152656719860821. doi:10.1177/2152656719860821
[7] George J, Khan H, Masood I, et al. Localized nasopharyngeal amyloidosis: a case report[J]. Radiol Case Rep, 2022, 17(12): 4506-4509. doi:10.1016/j.radcr.2022.08.070
[8] Takumi K, Staziaki PV, Hito R, et al. Amyloidosis in the head and neck: CT findings with clinicopathological correlation[J]. Eur J Radiol, 2020, 128: 109034. doi:10.1016/j.ejrad.2020.109034
[9] 刘雅琴, 张立庆, 张佳程, 等. 头颈部淀粉样变性23例临床分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(1): 72-77. doi:10.6040/j.issn.1673-3770.0.2019.464 LIU Yaqin, ZHANG Liqing, ZHANG Jiacheng, et al. Amyloidosis of the head and neck: a clinicopathological study of 23 cases[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(1): 72-77. doi:10.6040/j.issn.1673-3770.0.2019.464
[10] 中国系统性轻链型淀粉样变性协作组, 国家肾脏疾病临床医学研究中心, 国家血液系统疾病临床医学研究中心, 等. 系统性轻链型淀粉样变性诊断和治疗指南(2021年修订)[J]. 中华医学杂志, 2021, 101(22): 1646-1656.
[11] Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens[J]. Blood, 2009, 114(24): 4957-4959. doi:10.1182/blood-2009-07-230722
[12] Nienhuis HLA, Bijzet J, Hazenberg BPC. The prevalence and management of systemic amyloidosis in western countries[J]. Kidney Dis, 2016, 2(1): 10-19. doi:10.1159/000444206
[13] Gertz MA. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment[J]. Am J Hematol, 2014, 89(12): 1132-1140. doi:10.1002/ajh.23828
[14] Kumar SK, Callander NS, Adekola K, et al. Systemic light chain amyloidosis, version 2.2023, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2023, 21(1): 67-81. doi:10.6004/jnccn.2023.0001
[15] Ehman EC, El-Sady MS, Kijewski MF, et al. Early detection of multiorgan light-chain amyloidosis by whole-body 18F-florbetapir PET/CT[J]. J Nucl Med, 2019, 60(9): 1234-1239. doi:10.2967/jnumed.118.221770[PubMed]
[16] Rubin J, Maurer MS. Cardiac amyloidosis: overlooked, underappreciated, and treatable[J]. Annu Rev Med, 2020, 71: 203-219. doi:10.1146/annurev-med-052918-020140
[17] Pearlman AN, Jeffe JS, Zynger DL, et al. Localized amyloidosis of the nasal and paranasal mucosa: a rare pathology[J]. Am J Otolaryngol, 2010, 31(2): 130-131. doi:10.1016/j.amjoto.2008.11.003
[18] Hall J, Rubinstein S, Lilly A, et al. Treatment of localized amyloid light chain amyloidosis with external beam radiation therapy[J]. Pract Radiat Oncol, 2022, 12(6): 504-510. doi:10.1016/j.prro.2022.03.011

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 0

No Suggested Reading articles found!

Amyloidosis of torus tubalis with middle ear effusion: a case report with literature review

PDF (PC)

Abstract

Cite this article

share this article

References

Related Articles 5

Metrics

Comments

Recommended 0

[1]	FENG Chen, JIN Xiaoxue, HAN Yingying, ZOU Juanjuan, LI Yanzhong, WANG Yan. Primary localized tonsil amyloidosis: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 99-103.
[2]	LIU Yaqin, ZHANG Liqing, ZHANG Jiacheng, DONG Weida, ZHOU Han. Amyloidosis of the head and neck: a clinicopathological study of 23 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(1): 72-77.
[3]	NI Jing, LEI Fei, BAI Dan, ZHOU Yun, MA Jianmei, HUANG Wei, WANG Chunyang. Expression of immunological markers in middle ear effusion in children with secretory otitis media [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 56-59.
[4]	CHEN Wu na, GAO Xingqiang. Clinical analysis of laryngeal amyloidosis in supragolttic portion: report of 3 cases and literature review [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(6): 49-51.
[5]	GENG Yang, WANG Hui-zhong, SUN Feng-lin, WANG Xiao, WANG Hai-peng, XU Rong, XIA Yong-jun. CO₂ laser treatment in subglottic amyloidosis (two cases report and a literature review) [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(2): 70-73.